LMOs and Synthetic Biology: A Funny Take on Biodiversity COPs

The Mandate of SBSTTA-26

Brinda Dass is the Gene Drive Policy Lead at Foundation for the National Institutes of Health, US and a member of the AHTEG who attended the SBSTTA-26 in Nairobi. Dass revealed that for the Nairobi meet, AHTEG was given the task of developing a special guideline on engineered gene drive and at SBSTTA, the major discussion on LMO and synthetic biology was centered around genetically modified mosquitoes.

Engineered Gene Drive Versus Genetically Engineered Products

Genetic engineering involves the direct modification of an organism’s DNA, often in a controlled environment, without necessarily influencing inheritance patterns in the wild. This technology is usually applied in agriculture, medicine, and industrial biotechnology. For example, BT cotton and other genetically modified (GM) crops.

The Arguments and the Questions

At SBSTTA, some participants indicated that despite days of discussions, several questions were left unanswered and that many parties and representatives of NGOs and indigenous peoples groups were not in agreement.

Recommendations of SBSTTA and the Future Course

According to a statement by the CBD Secretariat, on biosafety and biotechnology, the Parties recommended new voluntary guidance on the risk assessment on engineered gene drives. The recommended guidelines are aimed at strengthening transparency and scientific rigor in the process and continuing the detection and identification of LMOs.

Effects of LMOs and Synthetic Biology on Individuals

The discussion on LMOs and synthetic biology at the UN Biodiversity COPs may have an indirect impact on individuals, especially those living in regions where genetically modified organisms are extensively used in agriculture. Consumers may need to be more informed about the potential risks and benefits of these technologies on their health and the environment.

Global Implications of LMOs and Synthetic Biology

The recommendations and discussions regarding LMOs and synthetic biology at international forums like SBSTTA and CBD can influence global policies on biotechnology and biodiversity conservation. They may shape the future regulatory frameworks for genetic engineering technologies and their impact on ecosystems worldwide.

Conclusion

In conclusion, the discussions on LMOs and synthetic biology at the 26th SBSTTA meeting have highlighted the complexities and challenges associated with these emerging technologies. It is essential for nations to continue engaging in dialogue, conducting thorough risk assessments, and developing regulatory guidelines to ensure the responsible use of genetic engineering in biodiversity conservation.